Pharming Group N.V.

PHAR· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$12.67+3.60%

2026-11-02

Financials

Valuation Metrics

Pharming Group N.V.'s Market Cap is $895M. At end of 2025 it was $1.17B. Ranked #2492 of 3,118 in US market (top 80%), #1035 of 1,474 on NASDAQ (top 70%), #189 of 265 in Pharmaceuticals, Biotechnology & Life Sciences (top 71%) by Market Cap.

Investment Metrics(as of 2026-11-02)

Metric	Value	Rank
Size
Market Cap	$895M	US#2,492/3,118 Sec#189/265
Revenue	$366M	US#2,353/3,118 Sec#88/265
Net Income	$9M	US#2,159/3,118 Sec#72/265
Total Assets	$468M	US#2,789/3,118 Sec#171/265
Net Assets	$270M	US#2,559/3,118 Sec#160/265
Value
P/E	96.50x	US#2,080/3,118 Sec#62/265
P/B	3.31x	US#1,843/3,118 Sec#101/265
P/S	2.44x	US#1,451/3,118 Sec#38/265
EV/EBITDA	19.93x	US#1,863/3,118 Sec#47/265
FCF Yield	3.50%	US#1,676/3,118 Sec#49/265
Profitability
ROE	3.43%	US#1,920/3,118 Sec#59/265
ROA	1.98%	US#1,637/3,118 Sec#63/265
Op. Margin	3.37%	US#2,111/3,118 Sec#72/265
Revenue Growth	7.83%	US#1,463/3,118 Sec#105/265
Financial Health
Debt Ratio	73.01%	US#802/3,118 Sec#150/265
Total Debt	$113M	US#2,394/3,118 Sec#114/265
FCF	$31M	US#2,094/3,118 Sec#75/265
Cash	$158M	US#1,917/3,118 Sec#129/265
Current Ratio	3.01x	US#774/3,118 Sec#190/265
Net Debt/EBITDA	-1.05x	US#276/3,118 Sec#18/265
Performance
1Y Return	-3.28%	US#2,039/3,118 Sec#161/265
1M Return	29.95%	US#182/3,118 Sec#13/265
From 52W High	-40.63%	US#2,425/3,118 Sec#173/265
1Y MDD	-56.99%	US#2,648/3,118 Sec#193/265
Trading
Volume	19,544 shares	US#3,113/3,118 Sec#265/265
Trading Value	$246840.00	US#3,104/3,118 Sec#265/265
Per Share
EPS	$0.13	US#2,069/3,118 Sec#69/265
BPS	$3.83	US#2,373/3,118 Sec#141/265